Contrast Media & Molecular Imaging / 2018 / Article / Fig 3

Research Article

Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms

Figure 3

The overall survival of unresectable patients detected with dual tracers: (a) Kaplan-Meier survival curve for unresectable patients, (A) positive for both tracers, (B) 68Ga-DOTA-TATE only, and (C) 18F-FDG only; (b) unresectable NET patients with 68Ga-DOTA-TATE results (positive or negative); (c) unresectable NET patients with 18F-FDG results (positive or negative); (d) unresectable NEC patients with 68Ga-DOTA-TATE results (positive or negative).
(a)
(b)
(c)
(d)